Lei Yang

Hubei Grand Life Science & Technology Co., Ltd. engages in the manufacture and distribution of pharmaceutical products. Its main products include taurine, taurine powder, theanine, thearine powder, and L-carnitine series. The company was founded in 1958 and is headquartered in Huangshi, China.

Hubei Grand Life Science & Technology Co., Ltd. engages in the manufacture and distribution of pharmaceutical products. Its main products include taurine, taurine powder, theanine, thearine powder, and L-carnitine series. The company was founded in 1958 and is headquartered in Huangshi, China.

Hubei Grand Life Science & Technology Co., Ltd. engages in the manufacture and distribution of pharmaceutical products. Its main products include taurine, taurine powder, theanine, thearine powder, and L-carnitine series. The company was founded in 1958 and is headquartered in Huangshi, China.

Hubei Grand Life Science & Technology Co., Ltd. engages in the manufacture and distribution of pharmaceutical products. Its main products include taurine, taurine powder, theanine, thearine powder, and L-carnitine series. The company was founded in 1958 and is headquartered in Huangshi, China.

Hubei Grand Life Science & Technology Co., Ltd. engages in the manufacture and distribution of pharmaceutical products. Its main products include taurine, taurine powder, theanine, thearine powder, and L-carnitine series. The company was founded in 1958 and is headquartered in Huangshi, China.

Part of Grand Pharmaceutical Group Ltd., Hubei Bafeng Pharmaceuticals & Chemicals Share Co., Ltd. engages in the production and operation of amino acid API products. The company is based in Enshi, China. The Chinese company was founded in 1997. The CEO is Cheng Ping Cai. Hubei Bafeng Pharmaceuticals & Chemicals Share Co. was acquired by Grand Pharmaceutical Group Ltd. on September 27, 2022 for $39.99 million.

Part of Grand Pharmaceutical Group Ltd., Hubei Bafeng Pharmaceuticals & Chemicals Share Co., Ltd. engages in the production and operation of amino acid API products. The company is based in Enshi, China. The Chinese company was founded in 1997. The CEO is Cheng Ping Cai. Hubei Bafeng Pharmaceuticals & Chemicals Share Co. was acquired by Grand Pharmaceutical Group Ltd. on September 27, 2022 for $39.99 million.

Part of Grand Pharmaceutical Group Ltd., Hubei Bafeng Pharmaceuticals & Chemicals Share Co., Ltd. engages in the production and operation of amino acid API products. The company is based in Enshi, China. The Chinese company was founded in 1997. The CEO is Cheng Ping Cai. Hubei Bafeng Pharmaceuticals & Chemicals Share Co. was acquired by Grand Pharmaceutical Group Ltd. on September 27, 2022 for $39.99 million.